New Vivus CEO Resigns Over Health Issues

Source: PharmaManufacturing.com

Sep 03, 2013

reuters.com

Drugmaker Vivus Inc said Chief Executive Anthony Zook resigned for health reasons, barely a month and a half after he assumed the role 

Vivus's board on Tuesday named Seth H.Z. Fischer, a former senior executive at Johnson & Johnson, the new CEO. Fischer will also join the Vivus board.

Vivus had faced intense investor criticism for the launch of its diet pill Qsymia, leading to an investor revolt that ended with the revamp of the company's board and the appointment of Zook as CEO. Read more.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments